NCT04828252 is a NA clinical trial of Low level laser treatment in Osteoarthritis, Knee, sponsored by National Cheng-Kung University Hospital.

Who is sponsoring NCT04828252?

NCT04828252 is sponsored by National Cheng-Kung University Hospital.

What drugs are being tested in NCT04828252?

Interventions in NCT04828252: Low level laser treatment.

What condition does NCT04828252 study?

NCT04828252 studies Osteoarthritis, Knee.

Is NCT04828252 still recruiting?

NCT04828252 is currently completed. Last updated 22 June 2021.

Last reviewed 2021-06-22 · How we verify

NCT04828252

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Low Level Laser Intervention for Individuals With Knee Osteoarthritis

Completed NA Last updated 22 June 2021

What this trial tests

NA trial testing Low level laser treatment in Osteoarthritis, Knee in 56 participants. Completed in 4 June 2021.

Timeline

9 November 2020

Primary endpoint
4 June 2021

4 June 2021

Quick facts

Lead sponsor	National Cheng-Kung University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	56
Start date	9 November 2020
Primary completion	4 June 2021
Estimated completion	4 June 2021
Sites	1 location across Taiwan

Drugs / interventions tested

Low level laser treatment

Conditions studied

Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →

Sponsor

National Cheng-Kung University Hospital

Who can join

50 and older, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to investigate the intervention effects of low level laser for knee OA group

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effects of low-level laser therapy on muscle strength and functional outcomes in individuals with knee osteoarthritis: a double-blinded randomized controlled trial.
Jankaew A, You YL, Yang TH, Chang YW, et al · · 2023 · cited 18× · PMID 36599881 · DOI 10.1038/s41598-022-26553-9

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

NCT07525713 — Virtual Reality Mirror Therapy With Focused Object-Directed Attention System · NA · not yet recruiting
NCT07369271 — Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery · NA · not yet recruiting
NCT07262411 — Peer-based Recovery Program · NA · not yet recruiting
NCT07257926 — Prevention of Delayed Post-polypectomy Bleeding by Endoscopic Sucralfate Spray in High-risk Patients: A Randomized Contr · Phase 4 · not yet recruiting
NCT07269132 — Applying the ADDIE Model to Develop a Multimedia Program to Enhance Chemotherapy Knowledge and Self-Efficacy Among Inten · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04828252 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Cheng-Kung University Hospital
Last refreshed: 22 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04828252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing